Interventions for the interruption or reduction of the spread of respiratory viruses

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Jefferson, Tom ^a   Foxlee, R ^a   Del Mar, C ^a   Dooley, L ^a   Ferroni, E ^a   Hewak, B ^a   Prabhala, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CINAHL; CLINICAL PROTOCOL; CLINICAL RESEARCH; COCHRANE LIBRARY; EMBASE; EPIDEMIC; FLU LIKE SYNDROME; HUMAN; INFECTION COMPLICATION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MEDLINE; PANDEMIC; REVIEW; SAMPLE SIZE; SEASONAL VARIATION; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION;

EID: 42749102253     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006207     Document Type: Review

References (26)

1. Alderson P, Green S, Higgins J. Analysing and presenting results. In: DeeksJJ, HigginsJPT, AltmanDG editor(s). Cochrane Reviewer's Handbook 4.2.2 [updated March 2004]; Section 8. In: The Cochrane Library. Vol. Issue 1, Chichester, UK: John Wiley & Sons, Ltd, 2004.
2. Bonn D. Spared an influenza pandemic for another year?. Lancet 1997;349(9044):36.
3. Centers for Disease Control and Prevention. Infection Control Guidance for the Prevention and Control of Influenza in Acute-Care Facilities. http://www.cdc.gov/u/professionals/infectioncontrol/healthcarefacilities. htm (Accessed March 3rd 2006).
4. Centers for Disease Control and Prevention. 2004-2005 Interim Guidance for the Use of Masks to Control Influenza Transmission. http://www.cdc.gov/u/ professionals/infectioncontrol/maskguidance.htm (Accessed March 3rd 2006).
5. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. In: Cochrane Database of Systematic Reviews, 3, 2004.
6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
7. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Communicable Disease and Public Health 2000;3(1):32-8.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
10. Jefferson TO, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. In: Cochrane Database of Systematic Reviews, 2, 1999.
11. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005;365(9461):773-80.
12. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A. Safety of influenza vaccines in children. Lancet 2005;366(9488):803-4.
13. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in the elderly: systematic review. Lancet 2005;366(9492):1165-74.
14. Jefferson T. Microbial challenge studies of volunteers-a challenge worth accepting. Lancet 2005;366(9485):531-3.
15. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367(9507):303-13.
16. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for preventing and treating influenza A in adults. In: Cochrane Database of Systematic Reviews, 2, 2006.
17. Luby SP, Agboatwalla M, Feikin DR, Painter J, Billhimer W, Altaf A, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet 2005;366(9481):225-33.
18. Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children. In: Cochrane Database of Systematic Reviews, 3, 2003.
19. Shute N. SARS hit home. US News & World Report 2003;134(15): 38-42, 44.
20. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. American Journal of Public Health 1997; 87(12):1944-50.
21. Smith S, Demicheli V, Di Pietrantonj C, Harnden AR, Jefferson T, Matheson NJ, et al. Vaccines for preventing influenza in healthy children. In: Cochrane Database of Systematic Reviews, 1, 2006.
22. Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type b infections. In: Cochrane Database of Systematic Reviews, 4, 2003.
23. United States Department of Health and Human Services. HHS Pandemic Influenza Plan. Appendix B: Pandemic Influenza Background. www.hhs.gov/ pandemicu/plan/appendixb.html (Accessed 20 June 2006) 2005.
24. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/ oxford web.ppt (accessed 2 September 2005) 2005.
25. World Health Organization. WHO interim guidelines on clinical management of humans infected by influenza A(H5N1). http://www.who.int/csr/disease/ avian_influenza/ guidelines/clinicalmanage/en/index.html (Accessed 3 March 2006) 2004.
26. World Health Organization Writing Group. Non pharmaceutical interventions for pandemic influenza, national and community measures. Emerging Infectious Diseases 2006;12(1):88-94.